Identification of an Orally Active Opioid Receptor-like 1 (ORL1) Receptor Antagonist 4-{3-[(2 R )-2,3-Dihydroxypropyl]-2-oxo-2,3-dihydro-1 H -benzimidazol-1-yl}-1-[(1 S ,3 S ,4 R )-spiro[bicyclo[2.2.1]heptane-2,1′-cyclopropan]-3-ylmethyl]piperidine as Clinical Candidate